* MiMedx Group Inc MDXG.OQ MDXG.O is expected to show a
fall
in quarterly revenue when it reports results on May 3.
* The Marietta Georgia-based company is expected to report
a
9.8% decrease in revenue to $54.1 million from $59.97 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for MiMedx Group Inc is
for a
loss of 10 cents per share. For the same quarter last year, the
company reported a loss of 9 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MiMedx
Group Inc
is $11, above its last closing price of $3.95.
This summary was machine generated April 30 at 02:02 GMT. All
figures in US dollars unless otherwise stated